Know Cancer

or
forgot password

Clinical Evaluation of an Investigational Blood Creatinine Point-of-Care Test Device


N/A
18 Years
N/A
Not Enrolling
Both
Cancer

Thank you

Trial Information

Clinical Evaluation of an Investigational Blood Creatinine Point-of-Care Test Device


Inclusion Criteria:



- Written Informed Consent

- Must have a creatinine > or = to than 3.5 mg/dl

Exclusion Criteria:

- Patients who are less than 18 years of age

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Outcome Measure:

The primary outcomes would be, reduced wait time and increased patient satisfaction.

Outcome Time Frame:

conclusion of the study

Safety Issue:

No

Principal Investigator

Martin Fleisher, PhD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Memorial Sloan-Kettering Cancer Center

Authority:

United States: Institutional Review Board

Study ID:

07-023

NCT ID:

NCT00607529

Start Date:

August 2007

Completion Date:

May 2010

Related Keywords:

  • Cancer
  • Multiple Diseases

Name

Location

Memorial Sloan Kettering Cancer CenterNew York, New York  10021